FDA Adverse Event Injury Summary report: N

DAVINCI XI

MDR report key: 23556266 · Received November 14, 2025

Report

Report Number
2955842-2025-44669
Event Type
Injury
Date Received
November 14, 2025
Date of Event
September 11, 2024
Report Date
November 14, 2025
Manufacturer
INTUITIVE SURGICAL, INC
Product Code
NAY
PMA / PMN Number
K131861
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO INVESTIGATION COULD BE PERFORMED AS THE ARTICLE DID NOT PROVIDE ANY SPECIFIC INFORMATION REGARDING THE PROCEDURE DATE OR DA VINCI SYSTEM IDENTIFIERS. THERE WAS NO REPORT OF ANY DA VINCI PRODUCT ISSUES, AND NO INDICATION THAT ANY DA VINCI PRODUCTS CONTRIBUTED TO THE REPORTED COMPLICATIONS. A SYSTEM LOG REVIEW WAS NOT PERFORMED SINCE THERE IS INSUFFICIENT EVENT INFORMATION. SECTION B4 CURRENTLY CAPTURES THE DATE OF THE MEDWATCH SUBMISSION TO FDA. THE DATE THAT THE LITERATURE ARTICLE FIRST CAME TO THE ATTENTION OF INTUITIVE SURGICAL, INC. (ISI) WAS 17-OCT-2025. CITATION: NODA, K., ET AL. (2024). TOTALLY ENDOSCOPIC ROBOTIC REPAIR OF CORONARY SINUS ATRIAL SEPTAL DEFECT WITH CONCOMITANT TRICUSPID ANNULOPLASTY. GENERAL THORACIC AND CARDIOVASCULAR SURGERY CASES, 3(42). HTTPS://DOI.ORG/10.1186/S44215-024-00167-1.

Description of Event or Problem · 0

A REVIEW OF AN ARTICLE TITLED, "TOTALLY ENDOSCOPIC ROBOTIC REPAIR OF CORONARY SINUS ATRIAL SEPTAL DEFECT WITH CONCOMITANT TRICUSPID ANNULOPLASTY," WAS CONDUCTED. THE ARTICLE AIMED TO DESCRIBE A RARE CASE AND EVALUATE THE FEASIBILITY OF A TOTALLY ENDOSCOPIC ROBOTIC APPROACH FOR CORONARY SINUS ATRIAL SEPTAL DEFECT REPAIR WITH CONCOMITANT TRICUSPID ANNULOPLASTY. THE STUDY WAS A SINGLE-PATIENT CASE REPORT THAT ANALYZED 1 PATIENT WHO UNDERWENT A TOTALLY ENDOSCOPIC ROBOTIC REPAIR OF A CORONARY SINUS ATRIAL SEPTAL DEFECT AND TRICUSPID ANNULOPLASTY BETWEEN 16-APR-2024 AND 30-AUG-2024. THE PATIENT EXPERIENCED POSTOPERATIVE EPISODES OF PAROXYSMAL ATRIAL FIBRILLATION REQUIRING ANTICOAGULATION THERAPY. THE PATIENT WAS DISCHARGED ON POST-OPERATIVE DAY #12 AND WAS CLINICALLY WELL AFTER A YEAR. THE AUTHORS CONCLUDED THAT ROBOTIC TECHNOLOGY COULD OFFER A FEASIBLE ALTERNATIVE DUE TO ITS ABILITY TO PROVIDE A HIGH-QUALITY SURGICAL VIEW OF THIS ANOMALY. PER THE AUTHOR, THERE WAS NO DEVICE MALFUNCTIONS AND NO EVENTS WERE CAUSED BY THE DA VINCI SURGICAL SYSTEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2805111 DAVINCI XI PATIENT SIDE CART, 4-ARM NAY INTUITIVE SURGICAL, INC 380652 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 72 YR Male Required Intervention DA VINCI INSTRUMENTS AND ACCESSORIES.